Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI
· Real-Time Price · USD
14.19
-0.63 (-4.25%)
At close: Sep 12, 2025, 3:59 PM
14.50
2.18%
After-hours: Sep 12, 2025, 06:35 PM EDT
Denali Therapeutics Revenue
Denali Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending June 30, 2025, Denali Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
0
Employees
443
Market Cap
2.07B
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | -100.00% |
| Dec 31, 2023 | 330.53M | +204.74% |
| Dec 31, 2022 | 108.46M | +122.90% |
| Dec 31, 2021 | 48.66M | -85.50% |
| Dec 31, 2020 | 335.66M | +1158.19% |
| Dec 31, 2019 | 26.68M | -79.34% |
| Dec 31, 2018 | 129.16M | +Infinity% |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |